Abbott Laboratories revenue and financials
In the fiscal year ended December 2025, Abbott Laboratories reported revenue of $44.33B (+5.67% year over year). Net income was $6.52B, a net margin of 14.7%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +5.67%
- 2025 vs 2024
- Net income growth
- −51.32%
- 2025 vs 2024
- Net margin
- 14.7%
- 2024: 31.9%
How Abbott Laboratories is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 5.1% a year on average over the last 5 years
Compound annual growth rate: from $34.61B in 2020 to $44.33B in 2025.
Free cash flow equal to 73% of net income
Totals for fiscal years 2023–2025: free cash flow $18.81B, net income $25.65B.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 44,328 | 41,950 | 40,109 | 43,653 | 43,075 | 34,608 | 31,904 | 30,578 | 27,390 | 20,853 |
| Cost of revenue | 19,319 | 18,706 | 17,975 | 19,142 | 18,537 | 15,003 | 13,231 | 12,706 | 12,409 | 9,094 |
| Gross profit | 25,118 | 23,306 | 22,190 | 24,570 | 24,995 | 19,605 | 18,673 | 17,882 | 15,900 | 11,768 |
| Selling, general and administrative | 11,630 | 11,109 | 10,385 | 10,703 | 11,006 | 9,591 | 9,540 | 9,568 | 8,804 | 6,558 |
| Research and development | 2,942 | 2,844 | 2,741 | 2,888 | 2,742 | 2,420 | 2,440 | 2,300 | 2,260 | 1,442 |
| Operating income | 8,053 | 6,825 | 6,478 | 8,362 | 8,425 | 5,357 | 4,532 | 3,650 | 1,564 | 3,026 |
| EBIT | 8,917 | 7,496 | 7,220 | 9,113 | 9,204 | 5,462 | 4,757 | 3,838 | 2,938 | 3,218 |
| EBITDA | 12,033 | 10,714 | 10,463 | 12,380 | 12,742 | 8,789 | 7,771 | 7,116 | 5,957 | 4,569 |
| Interest expense | 493 | 559 | 637 | 558 | 533 | 546 | 670 | 826 | 904 | 431 |
| Pre-tax income | 8,466 | 7,013 | 6,664 | 8,306 | 8,211 | 4,968 | 4,077 | 2,873 | 2,231 | 1,413 |
| Income tax | 1,942 | -6,389 | 941 | 1,373 | 1,140 | 497 | 390 | 539 | 1,878 | 350 |
| Net income | 6,524 | 13,402 | 5,723 | 6,933 | 7,071 | 4,495 | 3,687 | 2,368 | 477 | 1,400 |
| Net income to common shareholders | 6,500 | 13,400 | 5,700 | 6,905 | 7,042 | 4,449 | 3,666 | 2,319 | 344 | 1,056 |
| Basic EPS | 3.73 | 7.67 | 3.28 | 3.94 | 3.97 | 2.52 | 2.07 | 1.34 | 0.27 | 0.94 |
| Diluted EPS | 3.72 | 7.64 | 3.26 | 3.91 | 3.94 | 2.50 | 2.06 | 1.33 | 0.27 | 0.94 |
| Average shares (basic) | 1,741 | 1,740 | 1,740 | 1,753 | 1,775 | 1,773 | 1,768 | 1,758 | 1,740 | 1,477 |
| Average shares (diluted) | 1,748 | 1,748 | 1,749 | 1,764 | 1,789 | 1,786 | 1,781 | 1,770 | 1,749 | 1,483 |
| Dividend per share | 2.40 | 2.24 | 2.08 | 1.92 | 1.82 | 1.53 | 1.32 | 1.16 | 1.08 | 1.05 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13,013 | 12,593 | 11,164 | 11,459 | 11,369 | 11,142 | 10,358 | 10,974 | 10,635 | 10,377 | 9,964 | 10,241 |
| Cost of revenue | 5,628 | 5,325 | 4,890 | 4,913 | 5,075 | 4,854 | 4,468 | 4,880 | 4,698 | 4,603 | 4,463 | 4,500 |
| Gross profit | 7,385 | 7,268 | 6,274 | 6,546 | 6,294 | 6,288 | 5,890 | 6,094 | 5,937 | 5,774 | 5,501 | 5,741 |
| Selling, general and administrative | 4,107 | 3,866 | 3,581 | 2,927 | 2,903 | 2,945 | 2,914 | 2,725 | 2,760 | 2,797 | 2,827 | 2,537 |
| Research and development | 920 | 892 | 767 | 720 | 766 | 725 | 716 | 728 | 713 | 698 | 684 | 578 |
| Operating income | 1,517 | 1,852 | 1,504 | 2,477 | 2,205 | 2,198 | 1,840 | 2,176 | 1,994 | 1,808 | 1,518 | 2,145 |
| EBIT | 1,517 | 1,852 | 1,504 | 2,477 | 2,205 | 2,198 | 1,840 | 2,176 | 1,994 | 1,808 | 1,518 | 2,145 |
| EBITDA | 2,773 | 2,912 | 2,307 | 3,269 | 2,996 | 2,975 | 2,596 | 2,983 | 2,795 | 2,613 | 2,323 | 2,958 |
| Interest expense | 350 | 351 | 174 | 120 | 121 | 121 | 131 | 136 | 142 | 140 | 141 | 159 |
| Pre-tax income | 1,231 | 1,524 | 1,449 | 2,358 | 2,180 | 2,150 | 1,778 | 2,030 | 1,940 | 1,607 | 1,436 | 1,795 |
| Income tax | 311 | 596 | 372 | 582 | 536 | 371 | 453 | -7,199 | 294 | 305 | 211 | 201 |
| Net income | 920 | 928 | 1,077 | 1,776 | 1,644 | 1,779 | 1,325 | 9,229 | 1,646 | 1,302 | 1,225 | 1,594 |
| Net income to common shareholders | 920 | 928 | 1,077 | 1,752 | 1,644 | 1,779 | 1,325 | 9,227 | 1,646 | 1,302 | 1,225 | 1,588 |
| Basic EPS | 0.53 | 0.53 | 0.62 | 1.00 | 0.94 | 1.02 | 0.76 | 5.28 | 0.95 | 0.75 | 0.70 | 0.91 |
| Diluted EPS | 0.53 | 0.53 | 0.61 | 1.00 | 0.94 | 1.01 | 0.76 | 5.26 | 0.94 | 0.74 | 0.70 | 0.91 |
| Average shares (basic) | 1,734 | 1,740 | 1,742 | 1,747 | 1,742 | 1,743 | 1,739 | 1,746 | 1,739 | 1,743 | 1,740 | 1,748 |
| Average shares (diluted) | 1,738 | 1,743 | 1,747 | 1,747 | 1,749 | 1,751 | 1,747 | 1,746 | 1,748 | 1,751 | 1,750 | 1,748 |
| Dividend per share | 0.63 | 0.63 | 0.63 | 0.63 | 0.59 | 0.59 | 0.59 | 0.59 | 0.55 | 0.55 | 0.55 | 0.55 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 86,713 | 81,414 | 73,214 | 74,438 | 75,196 | 72,548 | 67,887 | 67,173 | 76,250 | 52,666 |
| Current assets | 25,996 | 23,656 | 22,670 | 25,224 | 24,239 | 20,441 | 15,667 | 14,632 | 20,147 | 26,776 |
| Cash and equivalents | 8,522 | 7,616 | 6,896 | 9,882 | 9,799 | 6,838 | 3,860 | 3,844 | 9,407 | 18,620 |
| Short-term investments | 417 | 351 | 383 | 288 | 450 | 310 | 280 | 242 | 203 | 155 |
| Receivables | 7,929 | 6,925 | 6,565 | 6,218 | 6,487 | 6,414 | 5,425 | 5,182 | 5,249 | 3,248 |
| Inventory | 6,488 | 6,194 | 6,570 | 6,173 | 5,157 | 5,012 | 4,316 | 3,796 | 3,601 | 2,434 |
| Net property, plant and equipment | 12,942 | 11,733 | 11,276 | 10,278 | 10,112 | 10,130 | 8,972 | 7,563 | 7,607 | 5,705 |
| Goodwill | 24,035 | 23,108 | 23,679 | 22,799 | 23,231 | 23,744 | 23,195 | 23,254 | 24,020 | 7,683 |
| Other intangible assets | 5,526 | 6,647 | 8,815 | 10,454 | 12,739 | 14,784 | 17,025 | 18,942 | 21,473 | 4,539 |
| Long-term investments | 595 | 573 | 485 | 468 | 512 | 665 | 585 | 590 | 520 | 2,955 |
| Current liabilities | 16,496 | 14,157 | 13,841 | 15,489 | 13,105 | 11,907 | 10,863 | 9,012 | 8,912 | 6,660 |
| Accounts payable | 4,240 | 4,195 | 4,295 | 4,607 | 4,408 | 3,946 | 3,252 | 2,975 | 2,402 | 1,178 |
| Long-term debt | 12,929 | 14,125 | 14,679 | 16,773 | 18,050 | 18,534 | 17,938 | 19,366 | 27,718 | 20,684 |
| Total debt | 14,136 | 15,326 | 15,968 | 17,966 | 19,251 | 19,677 | 18,898 | 19,366 | 27,718 | 21,138 |
| Total liabilities | 33,942 | 33,513 | 34,387 | 37,533 | 39,172 | 39,545 | 36,586 | 36,451 | 45,152 | 31,949 |
| Total equity (incl. minority) | 52,771 | 47,901 | 38,827 | 36,905 | 36,024 | 33,003 | 31,301 | 30,722 | 31,098 | 20,717 |
| Retained earnings | 49,781 | 47,261 | 37,554 | 35,257 | 31,528 | 27,627 | 25,847 | 24,560 | 23,978 | 25,565 |
| Minority interest | 641 | 237 | 224 | 219 | 222 | 219 | 213 | 198 | 201 | 179 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 108,247 | 109,215 | 110,429 | 86,713 | 84,181 | 83,999 | 81,448 | 81,414 | 74,356 | 73,017 | 72,467 | 73,214 |
| Current assets | 23,496 | 24,517 | 25,508 | 25,996 | 24,839 | 24,468 | 23,153 | 23,656 | 23,802 | 23,119 | 22,376 | 22,670 |
| Cash and equivalents | 4,052 | 5,104 | 6,803 | 8,522 | 7,511 | 6,951 | 6,532 | 7,616 | 7,558 | 6,987 | 6,284 | 6,896 |
| Short-term investments | 246 | 499 | 492 | 417 | 222 | 331 | 312 | 351 | 230 | 232 | 367 | 383 |
| Receivables | 9,032 | 8,599 | 8,210 | 7,929 | 8,138 | 7,972 | 7,327 | 6,925 | 7,051 | 6,854 | 6,605 | 6,565 |
| Inventory | 7,337 | 7,315 | 6,989 | 6,488 | 6,708 | 6,954 | 6,639 | 6,194 | 6,813 | 6,814 | 6,827 | 6,570 |
| Net property, plant and equipment | 12,880 | 12,812 | 12,377 | 12,942 | 11,504 | 11,395 | 10,932 | 11,733 | 10,621 | 10,233 | 10,107 | 11,276 |
| Goodwill | 32,643 | 35,244 | 35,221 | 24,035 | 23,971 | 23,952 | 23,359 | 23,108 | 23,658 | 23,308 | 23,383 | 23,679 |
| Other intangible assets | 19,591 | 17,211 | 17,875 | 5,526 | 5,598 | 5,920 | 6,261 | 6,647 | 7,352 | 7,827 | 8,296 | 8,815 |
| Long-term investments | 781 | 783 | 781 | 595 | 626 | 643 | 606 | 573 | 589 | 566 | 501 | 485 |
| Current liabilities | 16,152 | 17,814 | 18,377 | 16,496 | 14,582 | 13,439 | 13,004 | 14,157 | 14,902 | 13,760 | 14,021 | 13,841 |
| Accounts payable | 4,656 | 4,794 | 4,679 | 4,240 | 4,123 | 4,306 | 4,214 | 4,195 | 4,034 | 4,125 | 4,178 | 4,295 |
| Long-term debt | 29,718 | 29,703 | 29,705 | 9,896 | 11,630 | 12,963 | 12,784 | 12,676 | 12,879 | 13,213 | 12,664 | 13,694 |
| Total debt | 31,438 | 32,720 | 34,136 | 14,136 | 12,975 | 13,470 | 13,290 | 15,326 | 15,046 | 14,845 | 14,705 | — |
| Total liabilities | 56,624 | 57,453 | 57,728 | 33,942 | 32,917 | 33,170 | 32,384 | 33,513 | 34,328 | 33,457 | 33,424 | 34,387 |
| Total equity (incl. minority) | 51,623 | 51,762 | 52,701 | 52,771 | 51,264 | 50,829 | 49,064 | 47,901 | 40,028 | 39,560 | 39,043 | 38,827 |
| Retained earnings | 49,638 | 49,794 | 49,956 | 49,781 | 49,103 | 48,467 | 47,715 | 47,261 | 39,056 | 38,354 | 38,011 | 37,554 |
| Minority interest | 596 | 652 | 640 | 641 | 310 | 264 | 253 | 237 | 232 | 242 | 233 | 224 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 9,566 | 8,558 | 7,261 | 9,581 | 10,533 | 7,901 | 6,136 | 6,300 | 5,570 | 3,203 |
| Depreciation and amortization | 1,434 | 1,340 | 1,277 | 1,254 | 1,491 | 1,195 | 1,078 | 1,100 | 1,046 | 803 |
| Capital expenditure | -2,171 | -2,207 | -2,202 | -1,777 | -1,885 | -2,177 | -1,638 | -1,394 | -1,135 | -1,121 |
| Investing cash flow | -2,422 | -2,338 | -3,133 | -1,740 | -2,008 | -2,215 | -1,815 | -1,356 | -9,618 | -248 |
| Financing cash flow | -6,309 | -5,404 | -7,091 | -7,636 | -5,494 | -2,779 | -4,289 | -10,391 | -5,281 | 11,147 |
| Dividends paid | -4,116 | -3,836 | -3,556 | -3,309 | -3,202 | -2,560 | -2,270 | -1,974 | -1,849 | -1,539 |
| Share repurchases | -893 | -1,295 | -1,227 | -3,795 | -2,299 | -403 | -718 | -238 | -117 | -522 |
| Debt issued | 5.0 | 223 | 23.0 | 54.0 | 4.0 | 1,283 | 1,842 | 4,009 | 6,742 | 14,934 |
| Debt repaid | -1,619 | -760 | -2,498 | -753 | -252 | -1,333 | -3,441 | -12,459 | -9,684 | -1,779 |
| Effect of exchange rates | 71.0 | -96.0 | -23.0 | -122 | -70.0 | 71.0 | -16.0 | -116 | 116 | -483 |
| Net change in cash | 906 | 720 | -2,986 | 83.0 | 2,961 | 2,978 | 16.0 | -5,563 | -9,213 | 13,619 |
| Free cash flow | 7,395 | 6,351 | 5,059 | 7,804 | 8,648 | — | — | — | — | — |
| Levered free cash flow | 6,289 | 5,610 | 4,990 | 7,340 | 7,675 | 5,269 | 3,843 | 4,842 | 3,893 | 1,755 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,737 | 2,488 | 1,315 | 3,315 | 2,787 | 2,047 | 1,417 | 2,868 | 2,705 | 1,960 | 1,025 | 3,038 |
| Depreciation and amortization | 1,256 | 1,060 | 803 | 792 | 791 | 777 | 756 | 807 | 801 | 805 | 805 | 813 |
| Capital expenditure | -513 | -497 | -399 | -689 | -496 | -502 | -484 | -720 | -556 | -533 | -398 | -755 |
| Investing cash flow | -385 | -673 | -20,324 | -913 | -457 | -582 | -470 | -866 | -594 | -453 | -425 | -824 |
| Financing cash flow | -2,405 | -3,518 | 17,313 | -1,397 | -1,760 | -1,097 | -2,055 | -1,861 | -1,576 | -791 | -1,176 | -2,052 |
| Dividends paid | -1,094 | -1,102 | -1,098 | -1,030 | -1,031 | -1,029 | -1,026 | -958 | -960 | -961 | -957 | -888 |
| Share repurchases | -11.0 | -1,045 | -180 | -302 | -305 | -6.0 | -280 | -315 | -751 | -3.0 | -226 | -259 |
| Debt issued | -67.0 | 31.0 | 19,891 | 2.0 | 0.0 | 2.0 | 1.0 | 1.0 | 1.0 | 221 | — | 22.0 |
| Debt repaid | -1,333 | -1,405 | -1,416 | -72.0 | -493 | -17.0 | -1,037 | -614 | 42.0 | -61.0 | -127 | -961 |
| Effect of exchange rates | 1.0 | 4.0 | -23.0 | 6.0 | -10.0 | 51.0 | 24.0 | -83.0 | 36.0 | -13.0 | -36.0 | 25.0 |
| Net change in cash | -1,052 | -1,699 | -1,719 | 1,011 | 560 | 419 | -1,084 | 58.0 | 571 | 703 | -612 | 187 |
| Free cash flow | 1,224 | 1,991 | 916 | 2,626 | 2,291 | 1,545 | 933 | 2,148 | 2,149 | 1,427 | 627 | 2,283 |
| Levered free cash flow | 960 | 1,819 | 1,155 | 1,688 | 2,103 | 1,272 | 1,103 | 1,467 | 2,013 | 1,429 | 702 | 2,177 |
Financial statements of similar companies
Companies in the group: same industry, similar size
